These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2533356

  • 21. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM, De Souza RJ, Wood AJ, Green AR.
    Psychopharmacology (Berl); 1986; 90(4):488-93. PubMed ID: 2949333
    [Abstract] [Full Text] [Related]

  • 22. The effects of corticosterone on 5-HT receptor function in rodents.
    Young AH, MacDonald LM, St John H, Dick H, Goodwin GM.
    Neuropharmacology; 1992 May; 31(5):433-8. PubMed ID: 1388255
    [Abstract] [Full Text] [Related]

  • 23. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock.
    Heal DJ, Smith SL.
    Neuropharmacology; 1988 Dec; 27(12):1239-48. PubMed ID: 2977427
    [Abstract] [Full Text] [Related]

  • 24. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
    Takao K, Nagatani T, Kitamura Y, Yamawaki S.
    Eur J Pharmacol; 1997 Aug 27; 333(2-3):123-8. PubMed ID: 9314024
    [Abstract] [Full Text] [Related]

  • 25. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E.
    Pol J Pharmacol Pharm; 1992 Aug 27; 44(5):427-36. PubMed ID: 1363616
    [Abstract] [Full Text] [Related]

  • 26. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ, Rivet JM, Canton H, Le Marouille-Girardon S, Gobert A.
    J Pharmacol Exp Ther; 1993 Mar 27; 264(3):1364-76. PubMed ID: 8450471
    [Abstract] [Full Text] [Related]

  • 27. Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists.
    Gudelsky GA, Koenig JI, Meltzer HY.
    Neuropharmacology; 1987 Jul 27; 26(7A):707-12. PubMed ID: 2957607
    [Abstract] [Full Text] [Related]

  • 28. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J, Fukuda H, Nagao T, Ono H.
    Eur J Pharmacol; 1992 Sep 22; 220(2-3):237-42. PubMed ID: 1358651
    [Abstract] [Full Text] [Related]

  • 29. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
    Gudelsky GA, Koenig JI, Jackman H, Meltzer HY.
    Psychopharmacology (Berl); 1986 Sep 22; 90(3):403-7. PubMed ID: 2947256
    [Abstract] [Full Text] [Related]

  • 30. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S, Kreider MS, McGonigle P, Lucki I.
    Brain Res; 1990 Jun 18; 520(1-2):291-302. PubMed ID: 1698505
    [Abstract] [Full Text] [Related]

  • 31. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR, DeSouza RJ, Davies EM, Cross AJ.
    Br J Pharmacol; 1990 Jan 18; 99(1):41-6. PubMed ID: 1691944
    [Abstract] [Full Text] [Related]

  • 32. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec 18; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 33. Functional interaction between 5-HT1B and 5-HT1A or 5-HT2 receptors in mice.
    Chojnacka-Wójcik E.
    Pol J Pharmacol Pharm; 1992 Dec 18; 44(3):251-60. PubMed ID: 1470563
    [Abstract] [Full Text] [Related]

  • 34. 8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females.
    Haleem DJ, Kennett GA, Whitton PS, Curzon G.
    Eur J Pharmacol; 1989 May 30; 164(3):435-43. PubMed ID: 2527755
    [Abstract] [Full Text] [Related]

  • 35. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G, Sved AF, Murphy DL, Szemeredi K.
    Eur J Pharmacol; 1992 Jan 21; 210(3):285-9. PubMed ID: 1535317
    [Abstract] [Full Text] [Related]

  • 36. Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist.
    Kelder D, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug 21; 346(2):121-6. PubMed ID: 1448177
    [Abstract] [Full Text] [Related]

  • 37. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
    Bagdy G, Calogero AE, Murphy DL, Szemeredi K.
    Endocrinology; 1989 Nov 21; 125(5):2664-9. PubMed ID: 2551661
    [Abstract] [Full Text] [Related]

  • 38. Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat.
    Nash JF, Meltzer HY, Gudelsky GA.
    Eur J Pharmacol; 1988 Jul 14; 151(3):463-9. PubMed ID: 2905661
    [Abstract] [Full Text] [Related]

  • 39. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P, Serrano A, Scatton B.
    Synapse; 1990 Jul 14; 5(2):120-33. PubMed ID: 2137943
    [Abstract] [Full Text] [Related]

  • 40. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
    Hutson PH, Dourish CT, Curzon G.
    Eur J Pharmacol; 1988 Jun 10; 150(3):361-6. PubMed ID: 2970974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.